| pubmed-article:3840324 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C0020557 | lld:lifeskim |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C0015688 | lld:lifeskim |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C0080310 | lld:lifeskim |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:3840324 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:3840324 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3840324 | pubmed:dateCreated | 1985-11-6 | lld:pubmed |
| pubmed-article:3840324 | pubmed:abstractText | The effects of acute hypertriglyceridemia and of high levels of free fatty acids on the left ventricular ejection fraction were studied by radionuclide ventriculography in 20 subjects with and without coronary artery disease. An infusion of approximately 125 ml of a 20% fat emulsion over 25 minutes resulted in an increase of plasma triglycerides to the mean of 820 mg/dl and a fall of the left ventricular ejection fraction from the baseline mean of 62% to 58% (p less than 0.05). Ninety minutes after the intravenous administration of 5000 units of heparin, plasma free fatty acids rose to the mean of 4.6 mmol/L and the mean left ventricular ejection fraction increased to 69% (p less than 0.001). The observed changes in blood lipids were not associated with clinical or ECG evidence of myocardial ischemia. We conclude that acute hypertriglyceridemia causes slight depression of left ventricular performance, while high levels of free fatty acids augment it. However, neither hypertriglyceridemia per se nor its rapid conversion to free fatty acids are likely to cause angina in stable patients with coronary artery disease. | lld:pubmed |
| pubmed-article:3840324 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3840324 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3840324 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3840324 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:3840324 | pubmed:issn | 0002-8703 | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:KaplanEE | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:FreemanM LML | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:JohnsonBB | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:LoebH SHS | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:AckermanLL | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:PacoldII | lld:pubmed |
| pubmed-article:3840324 | pubmed:author | pubmed-author:ReidR WRW | lld:pubmed |
| pubmed-article:3840324 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3840324 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:3840324 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3840324 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3840324 | pubmed:pagination | 836-40 | lld:pubmed |
| pubmed-article:3840324 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:meshHeading | pubmed-meshheading:3840324-... | lld:pubmed |
| pubmed-article:3840324 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3840324 | pubmed:articleTitle | The effects of acute hypertriglyceridemia and high levels of free fatty acids on left ventricular function. | lld:pubmed |
| pubmed-article:3840324 | pubmed:publicationType | Journal Article | lld:pubmed |
